MacCollin M, Mautner V F
Neurology Service, Massachusetts General Hospital, Boston, USA.
Semin Pediatr Neurol. 1998 Dec;5(4):243-52. doi: 10.1016/s1071-9091(98)80003-x.
Neurofibromatosis 2 (NF2) is an autosomal-dominant condition that causes multiple benign nervous system tumors, especially vestibular schwannoma. Although frequently confused with the more common neurofibromatosis 1, NF2 presents a distinct set of diagnostic, genetic, and management issues. The presentation and natural history of NF2 differs in children and adults, with eighth nerve dysfunction often overshadowed by the effects of other tumors on the nervous system. Molecular diagnostics is an important tool for early recognition of NF2, and when performed in the context of appropriate counseling and follow-up, may lead to a better final outcome of the disease. Further research into the molecular genetic etiology of NF2 promises to broaden the possibilities of therapy for this devastating disorder.
神经纤维瘤病2型(NF2)是一种常染色体显性疾病,可导致多发性良性神经系统肿瘤,尤其是前庭神经鞘瘤。尽管NF2常与更常见的神经纤维瘤病1型混淆,但它存在一系列独特的诊断、遗传和管理问题。NF2在儿童和成人中的表现及自然病史有所不同,第八神经功能障碍常因其他肿瘤对神经系统的影响而被掩盖。分子诊断是早期识别NF2的重要工具,在适当的咨询和随访背景下进行时,可能会使该疾病获得更好的最终治疗效果。对NF2分子遗传病因的进一步研究有望拓宽针对这种破坏性疾病的治疗可能性。